495 related articles for article (PubMed ID: 14688045)
1. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
Hearn MJ; Cynamon MH
J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
Hearn MJ; Cynamon MH
Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
5. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.
Hearn MJ; Cynamon MH; Chen MF; Coppins R; Davis J; Joo-On Kang H; Noble A; Tu-Sekine B; Terrot MS; Trombino D; Thai M; Webster ER; Wilson R
Eur J Med Chem; 2009 Oct; 44(10):4169-78. PubMed ID: 19524330
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydro-2H-1,3,5-thiadiazine-5-(4-pyridylcarboxamide)-2-thione derivatives as prodrugs for isoniazid; synthesis, investigations and in vitro antituberculous activity.
Aboul-Fadl T; Hassanin K
Pharmazie; 1999 Apr; 54(4):244-7. PubMed ID: 10234734
[TBL] [Abstract][Full Text] [Related]
7. Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and antimycobacterial effect.
Horváti K; Mezo G; Szabó N; Hudecz F; Bosze S
J Pept Sci; 2009 May; 15(5):385-91. PubMed ID: 19319854
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of highly potent novel anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation.
Ramani AV; Monika A; Indira VL; Karyavardhi G; Venkatesh J; Jeankumar VU; Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2012 Apr; 22(8):2764-7. PubMed ID: 22440626
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
14. 5-Nitrothiazolylthiosemicarbazones: synthesis and antimycobacterial evaluation against tubercular and non-tubercular mycobacterial species.
Sriram D; Yogeeswari P; Senthilkumar P; Sangaraju D
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):105-10. PubMed ID: 19929750
[TBL] [Abstract][Full Text] [Related]
15. Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.
Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Apr; 21(7):2125-8. PubMed ID: 21320779
[TBL] [Abstract][Full Text] [Related]
16. Antituberculosis agents. VII. Synthesis and in vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
Foroumadi A; Soltani F; Asadipour A
Boll Chim Farm; 2003 Apr; 142(3):130-4. PubMed ID: 12806833
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives.
Ghosh S; Tiwari P; Pandey S; Misra AK; Chaturvedi V; Gaikwad A; Bhatnagar S; Sinha S
Bioorg Med Chem Lett; 2008 Jul; 18(14):4002-5. PubMed ID: 18579372
[TBL] [Abstract][Full Text] [Related]
18. N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity.
Sriram D; Yogeeswari P; Dhakla P; Senthilkumar P; Banerjee D
Bioorg Med Chem Lett; 2007 Apr; 17(7):1888-91. PubMed ID: 17276683
[TBL] [Abstract][Full Text] [Related]
19. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA
J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
